Cargando…
Dry eye management in a Sjögren’s syndrome mouse model by inhibition of p38-MAPK pathway
BACKGROUND: To investigate the therapeutic effect of p38-MAPK inhibitor, SB203580, on dry eye in a mouse model of Sjögren’s syndrome (MRL/lpr mice). METHODS: 18 female BALB/c mice and 44 female MRL/lpr mice were included. Mice were randomly assigned to the control or treatment group. The expression...
Autores principales: | Ma, Xiaoyun, Zou, Jun, He, Linping, Zhang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976089/ https://www.ncbi.nlm.nih.gov/pubmed/24443980 http://dx.doi.org/10.1186/1746-1596-9-5 |
Ejemplares similares
-
P40 Dry eyes and a dry mouth: is it Sjögren’s syndrome?
por: Sen, Ethan S, et al.
Publicado: (2022) -
Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
por: Coursey, Terry G, et al.
Publicado: (2014) -
Interferons and Dry Eye in Sjögren’s Syndrome
por: Ogawa, Yoko, et al.
Publicado: (2018) -
The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model
por: Shin, Soojung, et al.
Publicado: (2023) -
Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
por: Pal, Spandita, et al.
Publicado: (2023)